Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-538 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-16 |
filingDate |
1998-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2002-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2002509925-A |
titleOfInvention |
Benzoxazinone / benzothiazinone as serine protease inhibitor |
abstract |
(57) [Summary]nThe present invention discloses benzoxazinones and benzothiazinones which have an inhibitory effect on serine proteases such as factor Xa, thrombin and / or factor VIIa. The invention also relates to pharmaceutically acceptable salts of these compounds, pharmaceutically acceptable compositions containing these compounds or salts thereof, and disease states in mammals characterized by abnormal thrombosis. Disclosed are methods of using the same as therapeutic agents for treating or preventing. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002536446-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017001998-A |
priorityDate |
1998-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |